Bill > S1058

This bill aims to improve patient access to home infusion therapy under Medicare by making several key changes to existing law. The bill clarifies and expands Medicare coverage for home infusion services by including pharmacy services in the definition of home infusion therapy, allowing nurse practitioners and physician assistants to establish and review home infusion care plans, and modifying payment rules. Specifically, the bill introduces a new payment structure for home infusion therapy that allows reimbursement for each day a drug is administered, even if the therapy supplier is not physically present in the patient's home. For home infusion services between 2026 and 2030, the payment will reflect 5 hours of infusion for a particular therapy in a calendar day. The bill also expands the definition of home infusion drugs to include non-pump intravenous antibacterial, antifungal, and antiviral medications, ensuring that home infusion suppliers can be paid for these services. Additionally, the bill establishes new rules for billing home infusion supplies, preventing duplicate payments for items like tubing, catheters, and other related medical supplies. These changes are designed to make home infusion therapy more accessible and financially viable for patients and healthcare providers under the Medicare program.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/1058/all-info